Desogestrel

This classification denotes a therapeutic progestin with the molecular formula C22H30O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 81K9V7M3A3, chemically known as 18,19-dinorpregn-4-en-20-yn-17-ol, 13-ethyl-11-methylene-, (17alpha)- but generally known as desogestrel, which bears US NIH Compound Identifier 40973. European Medicines Agency schedules Desogestrel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07003MIG. The term DESOGESTREL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules desogestrel in its Anatomical Therapeutic Chemical (ATC) Classification. DESOGESTREL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule desogestrel under HS 29372300 and SITC 54153. As of Q4 2014, DESOGESTREL remains the US FDA Preferred Term for this commodity. Desogestrel bears US NLM identifiers UMLS ID C0057558 and NCI Concept Code C47476. SMILES: OC1(C2(C(C3C(C4C(=CCCC4)CC3)C(=C)C2)CC1)CC)C#C.